| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medication Errors | 29 | 2022 | 798 | 5.440 |
Why?
|
| Medical Order Entry Systems | 23 | 2022 | 545 | 4.830 |
Why?
|
| Diagnostic Errors | 18 | 2022 | 1256 | 4.020 |
Why?
|
| Drug Prescriptions | 20 | 2023 | 1636 | 3.440 |
Why?
|
| Malpractice | 8 | 2022 | 572 | 3.210 |
Why?
|
| Ambulatory Care | 14 | 2023 | 2707 | 2.890 |
Why?
|
| Primary Health Care | 26 | 2024 | 4556 | 2.250 |
Why?
|
| Electronic Prescribing | 7 | 2019 | 121 | 2.080 |
Why?
|
| Delayed Diagnosis | 5 | 2020 | 441 | 1.730 |
Why?
|
| Physicians | 15 | 2023 | 4569 | 1.560 |
Why?
|
| Continuity of Patient Care | 7 | 2021 | 1049 | 1.270 |
Why?
|
| Medical Errors | 11 | 2022 | 1297 | 1.190 |
Why?
|
| Ambulatory Care Facilities | 4 | 2021 | 934 | 1.190 |
Why?
|
| Communication | 15 | 2022 | 3748 | 1.170 |
Why?
|
| Diagnostic Tests, Routine | 6 | 2024 | 782 | 1.160 |
Why?
|
| Professional Role | 4 | 2023 | 306 | 1.140 |
Why?
|
| Physicians, Primary Care | 4 | 2022 | 592 | 1.090 |
Why?
|
| Electronic Health Records | 19 | 2024 | 4467 | 1.070 |
Why?
|
| Burnout, Professional | 4 | 2022 | 694 | 1.050 |
Why?
|
| Pharmaceutical Preparations | 8 | 2022 | 1070 | 1.050 |
Why?
|
| Decision Support Systems, Clinical | 8 | 2022 | 1164 | 0.960 |
Why?
|
| Medical Informatics | 4 | 2023 | 745 | 0.930 |
Why?
|
| Pharmacists | 4 | 2023 | 248 | 0.930 |
Why?
|
| Medication Systems, Hospital | 5 | 2019 | 158 | 0.920 |
Why?
|
| Insurance Claim Reporting | 2 | 2014 | 162 | 0.910 |
Why?
|
| Pharmacy and Therapeutics Committee | 3 | 2019 | 9 | 0.900 |
Why?
|
| Quality Assurance, Health Care | 9 | 2015 | 2211 | 0.880 |
Why?
|
| Respiratory Care Units | 1 | 2021 | 10 | 0.830 |
Why?
|
| Quality of Health Care | 15 | 2022 | 4370 | 0.830 |
Why?
|
| Safety Management | 7 | 2020 | 782 | 0.770 |
Why?
|
| Patient-Centered Care | 6 | 2018 | 1438 | 0.740 |
Why?
|
| Telephone | 5 | 2014 | 617 | 0.700 |
Why?
|
| Diagnostic Techniques and Procedures | 3 | 2018 | 214 | 0.690 |
Why?
|
| Physician-Patient Relations | 8 | 2018 | 3229 | 0.680 |
Why?
|
| Pneumonia, Viral | 3 | 2021 | 3241 | 0.640 |
Why?
|
| Humans | 159 | 2024 | 743811 | 0.640 |
Why?
|
| Appointments and Schedules | 2 | 2021 | 417 | 0.640 |
Why?
|
| Knowledge Bases | 1 | 2018 | 85 | 0.630 |
Why?
|
| Decision Making | 5 | 2019 | 3887 | 0.620 |
Why?
|
| Formularies as Topic | 2 | 2021 | 91 | 0.600 |
Why?
|
| Medical Record Linkage | 3 | 2005 | 284 | 0.590 |
Why?
|
| Crying | 1 | 2017 | 36 | 0.580 |
Why?
|
| Hospitals, Public | 5 | 2011 | 207 | 0.570 |
Why?
|
| Terminology as Topic | 3 | 2018 | 1546 | 0.550 |
Why?
|
| Disease | 1 | 2022 | 680 | 0.550 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 976 | 0.540 |
Why?
|
| Inappropriate Prescribing | 2 | 2016 | 202 | 0.530 |
Why?
|
| Patient Advocacy | 2 | 2015 | 353 | 0.530 |
Why?
|
| Awards and Prizes | 1 | 2020 | 375 | 0.520 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.510 |
Why?
|
| Social Justice | 2 | 2014 | 457 | 0.510 |
Why?
|
| Speech Recognition Software | 3 | 2014 | 72 | 0.510 |
Why?
|
| Staff Development | 1 | 2017 | 223 | 0.510 |
Why?
|
| Documentation | 8 | 2022 | 871 | 0.510 |
Why?
|
| Outpatients | 3 | 2018 | 1488 | 0.500 |
Why?
|
| Health Personnel | 3 | 2023 | 3217 | 0.490 |
Why?
|
| Epidemics | 1 | 2020 | 523 | 0.480 |
Why?
|
| Education, Medical | 4 | 2018 | 1722 | 0.470 |
Why?
|
| Referral and Consultation | 9 | 2023 | 3530 | 0.460 |
Why?
|
| Risk Management | 1 | 2017 | 571 | 0.460 |
Why?
|
| Ethics, Professional | 1 | 2013 | 102 | 0.450 |
Why?
|
| Altruism | 1 | 2015 | 204 | 0.450 |
Why?
|
| Anti-Obesity Agents | 1 | 2016 | 217 | 0.450 |
Why?
|
| Diet, Reducing | 1 | 2016 | 462 | 0.440 |
Why?
|
| Drug Therapy | 2 | 2009 | 496 | 0.440 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 737 | 0.430 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3134 | 0.420 |
Why?
|
| Patient Care Team | 7 | 2022 | 2528 | 0.410 |
Why?
|
| Attitude of Health Personnel | 7 | 2019 | 3839 | 0.400 |
Why?
|
| Delivery of Health Care | 7 | 2022 | 5319 | 0.400 |
Why?
|
| Social Responsibility | 1 | 2014 | 388 | 0.400 |
Why?
|
| Workflow | 5 | 2021 | 847 | 0.390 |
Why?
|
| Software | 3 | 2023 | 4440 | 0.390 |
Why?
|
| Mass Screening | 3 | 2018 | 5251 | 0.390 |
Why?
|
| Uncertainty | 4 | 2023 | 735 | 0.380 |
Why?
|
| Analgesics, Opioid | 5 | 2022 | 3677 | 0.380 |
Why?
|
| Organizational Policy | 2 | 2010 | 428 | 0.380 |
Why?
|
| Clinical Pharmacy Information Systems | 2 | 2003 | 103 | 0.380 |
Why?
|
| Prescription Drugs | 3 | 2012 | 593 | 0.370 |
Why?
|
| Counseling | 1 | 2018 | 1523 | 0.370 |
Why?
|
| Crowding | 1 | 2011 | 145 | 0.370 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 2064 | 0.370 |
Why?
|
| Pharmacies | 4 | 2018 | 150 | 0.370 |
Why?
|
| United States | 30 | 2022 | 69859 | 0.360 |
Why?
|
| Drug Implants | 1 | 2010 | 241 | 0.350 |
Why?
|
| Health Services Misuse | 1 | 2011 | 243 | 0.350 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2011 | 143 | 0.350 |
Why?
|
| Quality Improvement | 5 | 2019 | 3750 | 0.350 |
Why?
|
| Disease Management | 1 | 2020 | 2459 | 0.340 |
Why?
|
| Education, Pharmacy | 1 | 2009 | 35 | 0.340 |
Why?
|
| Drug Labeling | 2 | 2017 | 233 | 0.330 |
Why?
|
| Massachusetts | 11 | 2017 | 8660 | 0.330 |
Why?
|
| Emergency Service, Hospital | 5 | 2018 | 7658 | 0.320 |
Why?
|
| Data Mining | 1 | 2013 | 537 | 0.320 |
Why?
|
| Marketing | 1 | 2010 | 212 | 0.320 |
Why?
|
| Diagnostic Services | 2 | 2021 | 34 | 0.320 |
Why?
|
| Radiology | 1 | 2022 | 2099 | 0.310 |
Why?
|
| Checklist | 2 | 2012 | 832 | 0.310 |
Why?
|
| Patient Care | 3 | 2014 | 638 | 0.300 |
Why?
|
| Health Care Surveys | 7 | 2017 | 2453 | 0.300 |
Why?
|
| Hyperkalemia | 3 | 2016 | 218 | 0.300 |
Why?
|
| Weight Loss | 2 | 2016 | 2625 | 0.300 |
Why?
|
| Organizational Innovation | 3 | 2019 | 559 | 0.300 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 540 | 0.290 |
Why?
|
| Incidental Findings | 2 | 2013 | 689 | 0.290 |
Why?
|
| Qualitative Research | 5 | 2023 | 2682 | 0.290 |
Why?
|
| Chronic Disease | 3 | 2020 | 9139 | 0.280 |
Why?
|
| Patient Preference | 1 | 2014 | 889 | 0.280 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3587 | 0.280 |
Why?
|
| Drug Interactions | 5 | 2018 | 1460 | 0.280 |
Why?
|
| Pandemics | 3 | 2021 | 8385 | 0.280 |
Why?
|
| Humanism | 2 | 2019 | 89 | 0.270 |
Why?
|
| Financing, Personal | 2 | 2013 | 308 | 0.270 |
Why?
|
| Tablets | 1 | 2006 | 145 | 0.270 |
Why?
|
| Health Care Reform | 5 | 2022 | 1261 | 0.270 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 6773 | 0.260 |
Why?
|
| Conflict of Interest | 1 | 2010 | 544 | 0.260 |
Why?
|
| Retrospective Studies | 22 | 2024 | 77410 | 0.260 |
Why?
|
| Hormone Replacement Therapy | 1 | 2010 | 708 | 0.250 |
Why?
|
| Hospital Administration | 2 | 2017 | 353 | 0.250 |
Why?
|
| Drug Monitoring | 4 | 2016 | 953 | 0.250 |
Why?
|
| Clinical Laboratory Information Systems | 2 | 2003 | 108 | 0.250 |
Why?
|
| Emergency Medicine | 3 | 2015 | 1205 | 0.250 |
Why?
|
| Thyroid Function Tests | 1 | 2005 | 286 | 0.240 |
Why?
|
| Health Policy | 4 | 2018 | 2662 | 0.240 |
Why?
|
| Dyspnea | 1 | 2012 | 1303 | 0.240 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 3 | 2012 | 469 | 0.230 |
Why?
|
| Clinical Competence | 3 | 2009 | 4687 | 0.230 |
Why?
|
| Laboratories | 3 | 2021 | 462 | 0.230 |
Why?
|
| Hospitals, Proprietary | 2 | 2000 | 39 | 0.230 |
Why?
|
| Estrogens | 1 | 2010 | 1563 | 0.230 |
Why?
|
| Health Services Accessibility | 5 | 2011 | 5136 | 0.220 |
Why?
|
| Gemfibrozil | 1 | 2002 | 30 | 0.220 |
Why?
|
| Adult | 28 | 2022 | 213889 | 0.220 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3089 | 0.220 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2010 | 133 | 0.220 |
Why?
|
| Information Dissemination | 2 | 2013 | 1099 | 0.220 |
Why?
|
| American Public Health Association | 1 | 2022 | 1 | 0.220 |
Why?
|
| Internal Medicine | 1 | 2009 | 1009 | 0.210 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1917 | 0.210 |
Why?
|
| Middle Aged | 31 | 2023 | 213241 | 0.210 |
Why?
|
| Hospitals, Community | 3 | 2013 | 347 | 0.210 |
Why?
|
| Diagnosis, Differential | 3 | 2023 | 12954 | 0.200 |
Why?
|
| Feedback | 2 | 2020 | 795 | 0.200 |
Why?
|
| Internship and Residency | 5 | 2023 | 5787 | 0.200 |
Why?
|
| Single-Payer System | 1 | 2022 | 37 | 0.200 |
Why?
|
| Male | 40 | 2023 | 349776 | 0.200 |
Why?
|
| Female | 41 | 2023 | 380020 | 0.200 |
Why?
|
| Substance Abuse Detection | 2 | 2021 | 283 | 0.200 |
Why?
|
| Public Health | 1 | 2014 | 2603 | 0.200 |
Why?
|
| Patient Education as Topic | 3 | 2018 | 2278 | 0.190 |
Why?
|
| Thyroxine | 1 | 2005 | 667 | 0.190 |
Why?
|
| Social Identification | 1 | 2021 | 103 | 0.190 |
Why?
|
| Truth Disclosure | 1 | 2005 | 436 | 0.190 |
Why?
|
| Medically Underserved Area | 1 | 2003 | 252 | 0.190 |
Why?
|
| Systems Analysis | 1 | 2021 | 171 | 0.190 |
Why?
|
| Publications | 1 | 2023 | 195 | 0.190 |
Why?
|
| Medical Records Systems, Computerized | 6 | 2019 | 1204 | 0.180 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 975 | 0.180 |
Why?
|
| Hospitals, Voluntary | 1 | 2000 | 40 | 0.180 |
Why?
|
| Patient Participation | 3 | 2021 | 1457 | 0.180 |
Why?
|
| Health Services for the Aged | 1 | 2002 | 269 | 0.180 |
Why?
|
| Hypothyroidism | 1 | 2005 | 659 | 0.180 |
Why?
|
| False Positive Reactions | 2 | 2020 | 980 | 0.180 |
Why?
|
| Muscle Weakness | 1 | 2002 | 413 | 0.170 |
Why?
|
| Computers | 1 | 2002 | 602 | 0.170 |
Why?
|
| False Negative Reactions | 1 | 2020 | 588 | 0.170 |
Why?
|
| Cooperative Behavior | 5 | 2017 | 1503 | 0.170 |
Why?
|
| Community Health Centers | 1 | 2003 | 428 | 0.170 |
Why?
|
| Medical Audit | 2 | 2017 | 466 | 0.170 |
Why?
|
| Hospitalists | 1 | 2003 | 304 | 0.170 |
Why?
|
| Pharmacy | 1 | 2000 | 91 | 0.170 |
Why?
|
| Anthropology, Cultural | 1 | 2019 | 99 | 0.160 |
Why?
|
| Absorptiometry, Photon | 1 | 2005 | 1725 | 0.160 |
Why?
|
| Urinalysis | 1 | 2021 | 369 | 0.160 |
Why?
|
| Organizational Case Studies | 3 | 2017 | 299 | 0.160 |
Why?
|
| User-Computer Interface | 3 | 2022 | 1431 | 0.160 |
Why?
|
| Patient Simulation | 2 | 2013 | 309 | 0.160 |
Why?
|
| Hospitals, Teaching | 3 | 2015 | 1180 | 0.160 |
Why?
|
| Hypolipidemic Agents | 1 | 2002 | 606 | 0.160 |
Why?
|
| Insurance, Health | 2 | 2008 | 2492 | 0.150 |
Why?
|
| Leadership | 2 | 2017 | 1357 | 0.150 |
Why?
|
| Ecosystem | 1 | 2022 | 473 | 0.150 |
Why?
|
| Drug Utilization | 2 | 2016 | 1183 | 0.150 |
Why?
|
| Insurance Carriers | 2 | 2022 | 157 | 0.150 |
Why?
|
| Forecasting | 3 | 2023 | 2950 | 0.150 |
Why?
|
| Patient Identification Systems | 1 | 2017 | 79 | 0.150 |
Why?
|
| Medication Adherence | 3 | 2018 | 2063 | 0.140 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2016 | 92 | 0.140 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 1009 | 0.140 |
Why?
|
| Cation Exchange Resins | 1 | 2016 | 21 | 0.140 |
Why?
|
| Pyridines | 2 | 2012 | 2827 | 0.140 |
Why?
|
| Medication Reconciliation | 1 | 2018 | 151 | 0.140 |
Why?
|
| Potassium | 1 | 2000 | 1336 | 0.140 |
Why?
|
| Polystyrenes | 1 | 2016 | 112 | 0.140 |
Why?
|
| Self Report | 2 | 2019 | 3550 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 3921 | 0.130 |
Why?
|
| Osteoporosis | 1 | 2005 | 1577 | 0.130 |
Why?
|
| Telemedicine | 2 | 2023 | 2874 | 0.130 |
Why?
|
| Patient Satisfaction | 3 | 2014 | 3391 | 0.130 |
Why?
|
| Aged | 18 | 2023 | 163178 | 0.130 |
Why?
|
| Pain | 2 | 2016 | 4987 | 0.120 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 392 | 0.120 |
Why?
|
| National Health Insurance, United States | 1 | 1994 | 104 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2011 | 4260 | 0.120 |
Why?
|
| Access to Information | 1 | 2017 | 320 | 0.120 |
Why?
|
| Obesity | 1 | 2016 | 12744 | 0.120 |
Why?
|
| Databases, Factual | 4 | 2019 | 7729 | 0.120 |
Why?
|
| Academic Medical Centers | 6 | 2023 | 2760 | 0.120 |
Why?
|
| Feedback, Psychological | 1 | 2014 | 97 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 840 | 0.120 |
Why?
|
| Administrative Personnel | 1 | 2015 | 187 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1156 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 21675 | 0.110 |
Why?
|
| Reference Standards | 1 | 2017 | 1023 | 0.110 |
Why?
|
| Forms and Records Control | 1 | 1994 | 160 | 0.110 |
Why?
|
| Chicago | 5 | 2019 | 240 | 0.110 |
Why?
|
| Models, Organizational | 2 | 2011 | 574 | 0.110 |
Why?
|
| Data Collection | 4 | 2022 | 3339 | 0.110 |
Why?
|
| Personnel, Hospital | 1 | 2015 | 283 | 0.110 |
Why?
|
| Dermatology | 1 | 2022 | 872 | 0.110 |
Why?
|
| Total Quality Management | 1 | 1994 | 274 | 0.110 |
Why?
|
| Drugs, Generic | 1 | 2017 | 421 | 0.110 |
Why?
|
| Boston | 2 | 2023 | 9310 | 0.100 |
Why?
|
| Cognition | 2 | 2022 | 6759 | 0.100 |
Why?
|
| Interdisciplinary Communication | 2 | 2015 | 950 | 0.100 |
Why?
|
| Phenazines | 1 | 1991 | 58 | 0.100 |
Why?
|
| Gentian Violet | 1 | 1991 | 31 | 0.100 |
Why?
|
| Bone Density | 1 | 2005 | 3460 | 0.100 |
Why?
|
| Product Labeling | 1 | 2012 | 79 | 0.100 |
Why?
|
| Inpatients | 3 | 2022 | 2515 | 0.100 |
Why?
|
| Diagnosis-Related Groups | 2 | 2014 | 455 | 0.100 |
Why?
|
| Job Satisfaction | 1 | 2015 | 535 | 0.100 |
Why?
|
| Ambulatory Care Information Systems | 1 | 2011 | 86 | 0.100 |
Why?
|
| Theophylline | 1 | 1991 | 132 | 0.100 |
Why?
|
| Pilot Projects | 4 | 2014 | 8316 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1900 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2019 | 1041 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2019 | 941 | 0.100 |
Why?
|
| Systems Integration | 3 | 2013 | 440 | 0.090 |
Why?
|
| Regional Medical Programs | 1 | 2011 | 71 | 0.090 |
Why?
|
| Program Development | 1 | 2017 | 1314 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 11059 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 289 | 0.090 |
Why?
|
| Students, Medical | 2 | 2018 | 1862 | 0.090 |
Why?
|
| Health Services Research | 3 | 2022 | 1836 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 271 | 0.090 |
Why?
|
| Canada | 1 | 2015 | 2064 | 0.090 |
Why?
|
| Hospitals | 3 | 2011 | 3953 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 326 | 0.090 |
Why?
|
| Utah | 2 | 2000 | 126 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2013 | 239 | 0.090 |
Why?
|
| Colorado | 2 | 2000 | 163 | 0.090 |
Why?
|
| Sputum | 1 | 1991 | 476 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2015 | 1146 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1582 | 0.090 |
Why?
|
| Prospective Studies | 5 | 2023 | 53250 | 0.090 |
Why?
|
| Medicare | 2 | 2008 | 6565 | 0.080 |
Why?
|
| Hospitalization | 4 | 2016 | 10259 | 0.080 |
Why?
|
| Physician's Role | 2 | 2015 | 942 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 7784 | 0.080 |
Why?
|
| Young Adult | 9 | 2018 | 56392 | 0.080 |
Why?
|
| Reminder Systems | 2 | 2018 | 371 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 19894 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3503 | 0.080 |
Why?
|
| Spinal Stenosis | 1 | 2011 | 255 | 0.080 |
Why?
|
| Algorithms | 3 | 2019 | 13869 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 1991 | 546 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 1161 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 7172 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2002 | 3255 | 0.080 |
Why?
|
| Hospital Information Systems | 1 | 1990 | 395 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 805 | 0.080 |
Why?
|
| Medical Records | 2 | 1990 | 1412 | 0.080 |
Why?
|
| Professional Practice | 1 | 2009 | 326 | 0.070 |
Why?
|
| Staphylococcal Infections | 2 | 2010 | 1400 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1098 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14714 | 0.070 |
Why?
|
| Appendectomy | 1 | 2010 | 401 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2015 | 25032 | 0.070 |
Why?
|
| Time Factors | 3 | 2019 | 40038 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 57744 | 0.070 |
Why?
|
| Unnecessary Procedures | 1 | 2010 | 432 | 0.070 |
Why?
|
| Medically Uninsured | 2 | 2003 | 853 | 0.070 |
Why?
|
| Curriculum | 1 | 2019 | 3603 | 0.070 |
Why?
|
| Naproxen | 1 | 2006 | 99 | 0.070 |
Why?
|
| Drug Costs | 1 | 2013 | 1105 | 0.070 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1990 | 430 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 2001 | 1677 | 0.070 |
Why?
|
| Lorazepam | 1 | 2006 | 145 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2018 | 40545 | 0.060 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2005 | 93 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2010 | 717 | 0.060 |
Why?
|
| Research | 1 | 2013 | 1999 | 0.060 |
Why?
|
| Vibrio cholerae | 2 | 2001 | 807 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8637 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2008 | 782 | 0.060 |
Why?
|
| Cholera | 3 | 2001 | 785 | 0.060 |
Why?
|
| Drug Industry | 1 | 2010 | 746 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2015 | 2614 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2005 | 246 | 0.060 |
Why?
|
| Mammography | 1 | 2015 | 2475 | 0.060 |
Why?
|
| Appendicitis | 1 | 2010 | 645 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 1411 | 0.060 |
Why?
|
| Occult Blood | 1 | 2004 | 176 | 0.060 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 687 | 0.060 |
Why?
|
| Vancomycin | 2 | 2010 | 501 | 0.060 |
Why?
|
| Observer Variation | 1 | 2009 | 2592 | 0.060 |
Why?
|
| Simvastatin | 1 | 2006 | 360 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21733 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2015 | 2267 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5691 | 0.060 |
Why?
|
| Blood | 1 | 2005 | 596 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39001 | 0.060 |
Why?
|
| Anecdotes as Topic | 1 | 2002 | 57 | 0.050 |
Why?
|
| Tape Recording | 1 | 2022 | 76 | 0.050 |
Why?
|
| Income Tax | 1 | 2002 | 27 | 0.050 |
Why?
|
| Government Agencies | 1 | 2002 | 156 | 0.050 |
Why?
|
| Medicaid | 2 | 2008 | 2736 | 0.050 |
Why?
|
| Information Systems | 2 | 2016 | 410 | 0.050 |
Why?
|
| Adolescent | 9 | 2018 | 85729 | 0.050 |
Why?
|
| Capitation Fee | 1 | 2001 | 116 | 0.050 |
Why?
|
| Vancomycin Resistance | 1 | 2001 | 128 | 0.050 |
Why?
|
| Prevalence | 2 | 2015 | 15211 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2002 | 694 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2006 | 3912 | 0.050 |
Why?
|
| Patient Discharge | 2 | 1990 | 3317 | 0.050 |
Why?
|
| Autopsy | 1 | 1984 | 1020 | 0.050 |
Why?
|
| Cholera Vaccines | 2 | 2001 | 268 | 0.050 |
Why?
|
| Lebanon | 1 | 2001 | 229 | 0.050 |
Why?
|
| Nursing Service, Hospital | 1 | 2000 | 17 | 0.050 |
Why?
|
| Hospitals, County | 1 | 1980 | 17 | 0.050 |
Why?
|
| Exercise | 1 | 2016 | 5611 | 0.040 |
Why?
|
| Veterans Health | 1 | 2022 | 216 | 0.040 |
Why?
|
| Reading | 1 | 2024 | 554 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2003 | 421 | 0.040 |
Why?
|
| Antibodies, Bacterial | 3 | 2001 | 1470 | 0.040 |
Why?
|
| Health Priorities | 1 | 2003 | 380 | 0.040 |
Why?
|
| Health Care Sector | 1 | 2001 | 194 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 20121 | 0.040 |
Why?
|
| Heart Failure | 1 | 2003 | 10896 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2001 | 317 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2002 | 404 | 0.040 |
Why?
|
| Interdepartmental Relations | 1 | 1998 | 13 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 860 | 0.040 |
Why?
|
| Drug Information Services | 1 | 1998 | 51 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2011 | 2348 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2016 | 23327 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2017 | 70 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2021 | 594 | 0.040 |
Why?
|
| Ownership | 1 | 2000 | 332 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2005 | 880 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 526 | 0.040 |
Why?
|
| Guideline Adherence | 2 | 2011 | 2265 | 0.040 |
Why?
|
| Computer Systems | 1 | 1998 | 481 | 0.030 |
Why?
|
| Fee-for-Service Plans | 1 | 2001 | 694 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1980 | 397 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2011 | 3142 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2022 | 1101 | 0.030 |
Why?
|
| Patient Admission | 1 | 2003 | 1380 | 0.030 |
Why?
|
| Logistic Models | 3 | 2017 | 13404 | 0.030 |
Why?
|
| Phonetics | 1 | 2016 | 204 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 35122 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2715 | 0.030 |
Why?
|
| Management Quality Circles | 1 | 1994 | 21 | 0.030 |
Why?
|
| Australia | 1 | 2017 | 1167 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2016 | 6457 | 0.030 |
Why?
|
| Cost Savings | 1 | 2019 | 925 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cholecystitis, Acute | 1 | 2013 | 70 | 0.030 |
Why?
|
| Workload | 1 | 2019 | 849 | 0.030 |
Why?
|
| Alabama | 1 | 2013 | 98 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2001 | 2736 | 0.030 |
Why?
|
| Income | 1 | 2001 | 1913 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2542 | 0.030 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 254 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2016 | 566 | 0.020 |
Why?
|
| Narcotics | 1 | 2013 | 343 | 0.020 |
Why?
|
| Incidence | 1 | 2009 | 20948 | 0.020 |
Why?
|
| Poverty | 1 | 2003 | 2660 | 0.020 |
Why?
|
| World Health Organization | 1 | 2016 | 1317 | 0.020 |
Why?
|
| Attitude to Computers | 1 | 2011 | 202 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2538 | 0.020 |
Why?
|
| Daptomycin | 1 | 2010 | 73 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2291 | 0.020 |
Why?
|
| Oxazolidinones | 1 | 2010 | 96 | 0.020 |
Why?
|
| Angioedema | 1 | 2011 | 187 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2011 | 204 | 0.020 |
Why?
|
| Poisoning | 1 | 1991 | 249 | 0.020 |
Why?
|
| Patient Isolation | 1 | 2010 | 100 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2712 | 0.020 |
Why?
|
| Interinstitutional Relations | 1 | 2011 | 240 | 0.020 |
Why?
|
| Freezing | 2 | 2001 | 303 | 0.020 |
Why?
|
| Perception | 1 | 2016 | 1198 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2015 | 915 | 0.020 |
Why?
|
| Minocycline | 1 | 2010 | 163 | 0.020 |
Why?
|
| Child | 1 | 2017 | 77637 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 248 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 255 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 13980 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 692 | 0.020 |
Why?
|
| Delphi Technique | 1 | 2011 | 777 | 0.020 |
Why?
|
| Risk Factors | 2 | 2011 | 72252 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1989 | 11708 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 20827 | 0.020 |
Why?
|
| Politics | 1 | 1994 | 791 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2013 | 1064 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15067 | 0.020 |
Why?
|
| Commerce | 1 | 2012 | 592 | 0.020 |
Why?
|
| Memory | 1 | 2016 | 2173 | 0.020 |
Why?
|
| Community Health Services | 1 | 2011 | 650 | 0.020 |
Why?
|
| Patients | 1 | 2012 | 899 | 0.020 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5752 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1516 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1459 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7270 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 35409 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1404 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2011 | 1062 | 0.010 |
Why?
|
| Diagnosis | 1 | 1984 | 154 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6976 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2011 | 955 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4848 | 0.010 |
Why?
|
| Infection Control | 1 | 2010 | 964 | 0.010 |
Why?
|
| Quality Control | 1 | 2005 | 841 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1990 | 1738 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 474 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2047 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 338 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2001 | 331 | 0.010 |
Why?
|
| Thailand | 1 | 2001 | 299 | 0.010 |
Why?
|
| Specialization | 1 | 2005 | 775 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2007 | 1210 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2007 | 12020 | 0.010 |
Why?
|
| Illinois | 1 | 1980 | 119 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2013 | 6078 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1984 | 2369 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12243 | 0.010 |
Why?
|
| Medicine | 1 | 2005 | 945 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4839 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 3020 | 0.010 |
Why?
|
| Feces | 1 | 2001 | 1397 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1998 | 556 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 5983 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1998 | 995 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6485 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18355 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 2001 | 1771 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 63042 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 8480 | 0.010 |
Why?
|
| Vaccination | 1 | 1999 | 3275 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 4561 | 0.000 |
Why?
|
| Models, Biological | 1 | 2001 | 9582 | 0.000 |
Why?
|